Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of metabolic disorders. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://geraldpqry984903.therainblog.com/37649322/retaglutide-a-promising-glp-1-receptor-agonist